Stereotaxis unveils next generation RStar system clinical results at TCT2026

Stereotaxis unveils next generation RStar system clinical results at TCT2026
Stereotaxis unveils RStar data at TCT2026

Stereotaxis reported late-breaking clinical data featuring its next generation RStar system at TCT2026. The data focused on outcomes from robotic-assisted percutaneous coronary intervention (PCI) using the advanced technology, as highlighted alongside Robocath.

The results showcase ongoing innovation in robotic interventions within cardiovascular medicine, with industry stakeholders closely observing advancements in this field.

Stereotaxis recently launched its MAGiC ablation tip, designed to improve consistency in tissue contact and energy delivery for medical procedures, according to a past product debut announcement. The company also introduced the GenesisX system to expand the reach of robotic electrophysiology in cath labs and enhance patient care, as detailed in a separate report. These developments reflect Stereotaxis's ongoing efforts to advance its robotic platforms in cardiovascular medicine.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.